Sandip Kapadia
CIK 1677141 · CHIEF FINANCIAL OFFICER · last filed 2026-05-21
Sandip Kapadia is a CHIEF FINANCIAL OFFICER who has filed 45 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for PASG, was dated May 21, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $845.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$845.0K
3
45
-$4.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 0 | $5.81 | $0 | $84.0K | 9 | 2026-05-21 |
| HRMY | CHIEF FINANCIAL OFFICER | 24,521 | $34.46 | $845.0K | -$3.89M | 17 | 2026-01-28 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | CFO and Treasurer | 40,964 | $19.00 | $778.3K | -$306.3K | 19 | 2021-01-26 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | PASG | Grant (A) | — | $0 | EDGAR |
| 2026-01-28 | HRMY | Sell (S) | −3,746 | -$139.2K | EDGAR |
| 2026-01-26 | HRMY | Mixed | +3,746 | -$176.4K | EDGAR |
| 2026-01-20 | HRMY | Sell (S) | −20,961 | -$752.8K | EDGAR |
| 2025-12-09 | HRMY | Mixed | — | -$210.3K | EDGAR |
| 2025-11-25 | HRMY | Sell (S) | −3,427 | -$119.9K | EDGAR |
| 2025-10-02 | HRMY | Mixed | +20,961 | -$662.5K | EDGAR |
| 2025-08-19 | HRMY | Sell (S) | −21,573 | -$787.4K | EDGAR |
| 2025-05-30 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | HRMY | Sell (S) | −6,987 | -$227.4K | EDGAR |